Colinz Laboratories Limited (COLINZ.BO)
INR 70.32
(3.44%)
INR 70.32
(3.44%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.69 Million INR | 108.41% |
| 2022 | 2.73 Million INR | -43.57% |
| 2021 | 4.84 Million INR | -51.19% |
| 2020 | 9.92 Million INR | 160.79% |
| 2019 | 3.8 Million INR | -43.65% |
| 2018 | 6.75 Million INR | 60.6% |
| 2017 | 4.2 Million INR | -44.62% |
| 2016 | 7.59 Million INR | -5.01% |
| 2015 | 7.99 Million INR | -65.68% |
| 2014 | 23.29 Million INR | 23.86% |
| 2013 | 18.8 Million INR | -16.61% |
| 2012 | 22.55 Million INR | -5.7% |
| 2011 | 23.91 Million INR | -15.98% |
| 2010 | 28.46 Million INR | -8.62% |
| 2009 | 31.15 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 8.1 Million INR | 0.0% |
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 4.6 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 5.69 Million INR | 108.41% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 5.69 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 5.7 Million INR | 0.0% |
| 2022 FY | 2.73 Million INR | -43.57% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 2.73 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 4.84 Million INR | 0.0% |
| 2021 Q2 | 8.81 Million INR | 0.0% |
| 2021 FY | 4.84 Million INR | -51.19% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 2.6 Million INR | 0.0% |
| 2020 Q4 | 9.92 Million INR | 0.0% |
| 2020 FY | 9.92 Million INR | 160.79% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 3.8 Million INR | 0.0% |
| 2019 Q2 | 2.96 Million INR | 0.0% |
| 2019 FY | 3.8 Million INR | -43.65% |
| 2018 FY | 6.75 Million INR | 60.6% |
| 2018 Q2 | 7.85 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 6.75 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 8.52 Million INR | 0.0% |
| 2017 FY | 4.2 Million INR | -44.62% |
| 2017 Q4 | 4.2 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 7.59 Million INR | -5.01% |
| 2016 Q4 | 7.59 Million INR | 0.0% |
| 2016 Q2 | 16.15 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 FY | 7.99 Million INR | -65.68% |
| 2015 Q4 | 15.96 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 19.05 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 23.29 Million INR | 23.86% |
| 2014 Q4 | 23.29 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 16.51 Million INR | 0.0% |
| 2013 Q4 | 18.8 Million INR | 0.0% |
| 2013 FY | 18.8 Million INR | -16.61% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q2 | 20.57 Million INR | 0.0% |
| 2012 FY | 22.55 Million INR | -5.7% |
| 2012 Q4 | 22.55 Million INR | 0.0% |
| 2011 Q4 | 23.91 Million INR | 0.0% |
| 2011 FY | 23.91 Million INR | -15.98% |
| 2010 FY | 28.46 Million INR | -8.62% |
| 2009 FY | 31.15 Million INR | 0.0% |
| 2009 Q4 | 31.15 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | 77.71% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 98.696% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | 1.299% |
| Vasundhara Rasayans Limited | 19.46 Million INR | 70.727% |
| Sunil Healthcare Limited | 661.51 Million INR | 99.139% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.944% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 99.189% |
| Patidar Buildcon Limited | 25.32 Million INR | 77.499% |
| Roopa Industries Limited | 258.54 Million INR | 97.796% |
| Smruthi Organics Limited | 117.03 Million INR | 95.131% |
| Trident Lifeline Limited | 184.1 Million INR | 96.905% |
| PANJON LTD. | 14.36 Million INR | 60.345% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 93.322% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | 85.263% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | 61.5% |
| Anuh Pharma Limited | 26.92 Million INR | 78.84% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -420.841% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -800.158% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 99.46% |
| Trimurthi Limited | - INR | -Infinity% |
| Shukra Pharmaceuticals Limited | 31.53 Million INR | 81.933% |
| Norris Medicines Limited | 215.23 Million INR | 97.353% |
| Zenlabs Ethica Limited | 148.59 Million INR | 96.165% |
| Vikram Thermo (India) Limited | 70.43 Million INR | 91.911% |
| ANG Lifesciences India Limited | 728.36 Million INR | 99.218% |
| Parmax Pharma Limited | 53.72 Million INR | 89.394% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | 69.933% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 99.456% |
| Makers Laboratories Limited | 194.92 Million INR | 97.077% |
| Lactose (India) Limited | 392.52 Million INR | 98.548% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 99.004% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | 41.203% |
| Bacil Pharma Limited | 984 Thousand INR | -479.065% |
| PRAVEG LIMITED | 596.11 Million INR | 99.044% |
| Denis Chem Lab Limited | 10.46 Million INR | 45.526% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 99.419% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Godavari Drugs Limited | 556.24 Million INR | 98.976% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | 90.969% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 98.437% |
| Vivanza Biosciences Limited | 51.69 Million INR | 88.978% |
| Phaarmasia Limited | 1.44 Million INR | -295.42% |
| Sastasundar Ventures Limited | 38.82 Million INR | 85.325% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | 79.418% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 98.764% |
| Mercury Laboratories Limited | 55.53 Million INR | 89.74% |
| Gennex Laboratories Limited | 57.2 Million INR | 90.039% |
| BDH Industries Limited | 86.9 Million INR | 93.444% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Concord Drugs Limited | 165.94 Million INR | 96.566% |
| Bharat Parenterals Limited | 1.57 Billion INR | 99.638% |
| Beryl Drugs Limited | 50.93 Million INR | 88.814% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | 92.846% |
| Evoq Remedies Limited | 42.38 Million INR | 86.556% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 95.539% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 99.293% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -16180.0% |
| Kerala Ayurveda Limited | 675.77 Million INR | 99.157% |
| Cian Healthcare Limited | 556.91 Million INR | 98.977% |
| Trinity League India Limited | 242 Thousand INR | -2254.545% |
| Syschem (India) Limited | 4.5 Million INR | -26.622% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 99.592% |
| Natural Capsules Limited | 1.09 Billion INR | 99.477% |
| Auro Laboratories Limited | 262.43 Million INR | 97.829% |